Fleet Bioprocessing Ltd. are proud to report that we received zero non-conformances in our latest audit against the requirements of ISO 9001:2015 and ISO 13485:2016, which was carried out by NQA in November. In addition, the audit recognised Fleet as achieving "industry best practice" in three areas.
top of page
Recent Posts
See AllRecently, one of Fleet Bioprocessing’s experts was asked to consult on a project. Nothing unusual about that, Fleet experts regularly act as consultants for clients advising on bioconjugation, ELISA a
One of the most notable recent innovations in the field of medical science is the development of Antibody-Drug Conjugates (ADCs). ADCs represent a revolutionary approach in cancer treatment, marrying
At Fleet Bioprocessing Ltd., we take pride in being a Gyrolab Certified Assay Transfer and Development Partner. Fleet Bioprocessing Ltd. enjoys global recognition for our proficiency in bioconjugation
bottom of page